Takayanagi H - Search Results

1

New insights into osteoclastogenic signaling mechanisms.

Nakashima T, Hayashi M, Takayanagi H. Nakashima T, et al. Among authors: takayanagi h. Trends Endocrinol Metab. 2012 Nov;23(11):582-90. doi: 10.1016/j.tem.2012.05.005. Epub 2012 Jun 15. Trends Endocrinol Metab. 2012. PMID: 22705116 Review.

2

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.

Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S. Takayanagi H, et al. Arthritis Rheum. 2000 Feb;43(2):259-69. doi: 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W. Arthritis Rheum. 2000. PMID: 10693864 Free article.

3

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.

Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T. Takayanagi H, et al. Nature. 2002 Apr 18;416(6882):744-9. doi: 10.1038/416744a. Nature. 2002. PMID: 11961557

4

Signaling crosstalk between RANKL and interferons in osteoclast differentiation.

Takayanagi H, Kim S, Taniguchi T. Takayanagi H, et al. Arthritis Res. 2002;4 Suppl 3(Suppl 3):S227-32. doi: 10.1186/ar581. Epub 2002 May 9. Arthritis Res. 2002. PMID: 12110142 Free PMC article. Review.

5

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Takayanagi H, et al. Dev Cell. 2002 Dec;3(6):889-901. doi: 10.1016/s1534-5807(02)00369-6. Dev Cell. 2002. PMID: 12479813 Free article.

6

The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.

Urushibara M, Takayanagi H, Koga T, Kim S, Isobe M, Morishita Y, Nakagawa T, Löeffler M, Kodama T, Kurosawa H, Taniguchi T. Urushibara M, et al. Among authors: takayanagi h. Arthritis Rheum. 2004 Mar;50(3):794-804. doi: 10.1002/art.20206. Arthritis Rheum. 2004. PMID: 15022321 Free article.

7

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.

Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T. Koga T, et al. Among authors: takayanagi h. Nature. 2004 Apr 15;428(6984):758-63. doi: 10.1038/nature02444. Nature. 2004. PMID: 15085135

8

Mechanistic insight into osteoclast differentiation in osteoimmunology.

Takayanagi H. Takayanagi H. J Mol Med (Berl). 2005 Mar;83(3):170-9. doi: 10.1007/s00109-004-0612-6. Epub 2005 Jan 26. J Mol Med (Berl). 2005. PMID: 15776286 Review.

9

[GeneChip analysis for osteoimmunology].

Takayanagi H. Takayanagi H. Nihon Rinsho Meneki Gakkai Kaishi. 2005 Apr;28(2):79-85. doi: 10.2177/jsci.28.79. Nihon Rinsho Meneki Gakkai Kaishi. 2005. PMID: 15863966 Free article. Review. Japanese.

10

Inflammatory bone destruction and osteoimmunology.

Takayanagi H. Takayanagi H. J Periodontal Res. 2005 Aug;40(4):287-93. doi: 10.1111/j.1600-0765.2005.00814.x. J Periodontal Res. 2005. PMID: 15966905 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page